About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 397 record(s)
Nothing to report this month
Organization: Jacques Cartier and Champlain Bridges Incorporated
Nothing to report this month
Organization: Office of the Information Commissioner of Canada
Nothing to report this month
Organization: Sahtu Land and Water Board
Req # A-2019-001009
Adverse Drug Reactions (ADRs) for Chlorhexidine. Report numbers: 000725334, 000725411, 000725428, 000725434, 000725439, 000725442, 000725446, 000725500, 000725506, E2B_02466826, E2B_02467708, E2B_02467710, E2B_02469532, E2B_02479840, 000725624,…Organization: Health Canada
September 2022
Req # A-2019-001729
Adverse Drug Reactions (ADRs) for immunoglobulin (human). Report numbers: 000729698, 000729737, 000729753, E2B_02721074, E2B_02725284, E2B_02745409, E2B_02745430, E2B_02757454, E2B_02757460, E2B_02757483, E2B_02758498, E2B_02758510, E2B_02761164,…Organization: Health Canada
September 2022
Req # A-2020-000935
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-109891-294.Organization: Health Canada
September 2022
Req # A-2020-001118
Adverse Drug Reactions (ADRs). Report numbers: E2B_02194141, E2B_02194231, E2B_02196619, E2B_02196705, E2B_02196717, E2B_02199201, E2B_02199223, E2B_02199231, E2B_02199293, E2B_02199808, E2B_02200059, E2B_02201762, E2B_02202036, E2B_02202050,…Organization: Health Canada
September 2022
Req # A-2020-001145
Adverse Drug Reactions (ADRs). Report numbers: E2B_02321406, E2B_02321840, E2B_02323070, E2B_02323093, E2B_02323110, E2B_02323596, E2B_02323621, E2B_02324669, E2B_02325522, E2B_02326954, E2B_02326990, E2B_02327172, E2B_02328369, E2B_02328379,…Organization: Health Canada
September 2022
Req # A-2020-001184
Adverse Drug Reactions (ADRs). Report numbers: E2B_02424240, E2B_02424378, E2B_02424435, E2B_02424630, E2B_02425161, E2B_02425170, E2B_02425179, E2B_02427052, E2B_02427055, E2B_02427212, E2B_02427224, E2B_02427228, E2B_02427229, E2B_02427233,…Organization: Health Canada
September 2022
Req # A-2020-001345
Adverse Drug Reactions (ADRs). Report numbers: E2B_02079242, E2B_02086576, E2B_02087040, E2B_02207354, E2B_02218589, E2B_02247236, E2B_02251088, E2B_02271649, E2B_02274332, E2B_02285866, E2B_02290975, E2B_02297390, E2B_02297391.Organization: Health Canada
September 2022